Works matching IS 18607179 AND DT 2025 AND VI 20 AND IP 6


Results: 22
    1
    2
    3
    4
    5
    6

    Investigating the C2 Modulation of the Imidazo[1,2‐a]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

    Published in:
    ChemMedChem, 2025, v. 20, n. 6, p. 1, doi. 10.1002/cmdc.202400862
    By:
    • Tisseur, Lhana;
    • Cojean, Sandrine;
    • Gassama, Khadidiatou;
    • Logé, Cédric;
    • Pagniez, Fabrice;
    • Cavé, Christian;
    • Bernadat, Guillaume;
    • Loiseau, Philippe M.;
    • Bach, Stéphane;
    • Thiéfaine, Jérôme;
    • Picot, Carine;
    • Tomasoni, Christophe;
    • Leclercq, Olivier;
    • Baratte, Blandine;
    • Robert, Thomas;
    • Le Pape, Patrice;
    • Rachidi, Najma;
    • Bazin, Marc‐Antoine;
    • Marchand, Pascal
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Third‐Generation CD73 Inhibitors Based on a 4,6‐Disubstituted‐2‐Thiopyridine Scaffold.

    Published in:
    ChemMedChem, 2025, v. 20, n. 6, p. 1, doi. 10.1002/cmdc.202400662
    By:
    • Grosjean, Félix;
    • Shaldaeva, Maria;
    • Cros‐Perrial, Emeline;
    • Rodriguez, Céline;
    • Ghoteimi, Rayane;
    • Lebrun, Aurélien;
    • Gao, Zhan‐Guo;
    • Uttaro, Jean‐Pierre;
    • Mathé, Christophe;
    • Jacobson, Kenneth A.;
    • Petter Jordheim, Lars;
    • Ménétrier‐Caux, Christine;
    • Chaloin, Laurent;
    • Peyrottes, Suzanne
    Publication type:
    Article
    21
    22